The US Food and Drug Administration recently approved a phase II clinical trial of afamelanotide (SCENESSE, Clinuvel Pharmacueticals Ltd) combined with narrowband UV-B therapy for the treatment of vitiligo.4 We report the case of a 25-year-old man who came to our department for the sudden eruption of multiple melanocytic nevi and rapid transformation of existing nevi
Insurers and policymakers arent just asking, Is this a good treatment? David Kim, a health economist at the University of Chicago, said in the report
Sciatica is a painful condition that is caused by pressure or damage to the sciatic nerve or an associated nerve in the lower back and spinal area
That's the power of peptides
This dual reaction is typically due to the bodys adjustment to the medication
The organization has consistently earned the highest quality and patient-satisfaction rankings from the National Committee for Quality Assurance (NCQA), Leapfrog Group, JD Power and Medicare